U.S. stocks edged lower; Q2 GDP rose more than expected, Nvidia disappoints
Investing.com - Piper Sandler has reiterated its Overweight rating and $27.00 price target on Indivior (NASDAQ:INDV) following the company’s detailed presentation of its efficiency initiatives. According to InvestingPro data, the stock is trading near its Fair Value, with two analysts recently revising earnings estimates upward for the upcoming period.
The pharmaceutical company recently provided additional information on Phase 1 of its "Action Agenda," which includes organizational streamlining and exploration of strategic options for its Opvee product and ex-U.S. business operations.
Piper Sandler expects these initiatives to result in improved operating margins beginning in 2025, according to its research note.
The firm also noted more stable competitive dynamics surrounding Indivior’s Sublocade product, highlighting continued underpenetration of long-acting injectable buprenorphine modalities in the market.
These factors collectively point to "ample room for steady long-term top-line/EBITDA growth," which Piper Sandler believes justifies further multiple expansion from the current enterprise value to 2026 estimated EBITDA ratio of approximately 8x.
In other recent news, Indivior PLC reported a significant earnings beat for the second quarter of 2025. The company achieved earnings per share of $0.51, surpassing analysts’ forecasts of $0.24 by 112.5%. Additionally, Indivior’s revenue reached $302 million, exceeding expectations by 24.96%. The company also announced it will incur restructuring charges estimated between $39 million and $50 million as part of a cost-cutting plan to streamline operations. These charges are expected to be recognized in the third and fourth quarters of 2025. In a separate development, Indivior updated its Chief Financial Officer Ryan Preblick’s employment agreements, aligning them with current forms for U.S.-based executives. Notably, there were no changes to Preblick’s compensation, which includes an annual base salary of $558,819 and eligibility for a cash bonus and long-term incentive awards. These recent developments highlight Indivior’s ongoing efforts to optimize its operations and align executive agreements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.